Halaman 3 - Rontgen Dada Dokter Terbaik di Turquia - TOP-133 dokter

Education and Specialization

• Hacettepe University Faculty of Medicine – English Medical Education
• Akdeniz University Faculty of Medicine – Internal Medicine – Residency
• Akdeniz University Hospital – Nephrology – Subspecialty Training
• San Bortolo Hospital, Vicenza, Italy – Critical Care Nephrology and Transplantation – Fellowship
• Hacettepe University Faculty of Medicine – Associate Professorship

Professional Memberships

1. Turkish Society of Nephrology (TND)
2. European Society of Nephrology (ERA-EDTA)
3. Middle East Society of Organ Transplantation (MESOT)
4. International Society of Nephrology (ISN)

Dr. Fırat Oruç is an Orthopedics and Traumatology specialist with 20 years of experience (since 2005). He has worked at Medical Park Antalya Hospital Complex since 2008. He previously worked at Private Lara Hospital (2005–2007) and completed his military service at GATA Istanbul (2007–2008).

Clinical focus includes knee, shoulder, and hip surgery; joint prostheses; soft tissue and bone tumors; pediatric orthopedics; and hand surgery. He earned his medical degree from Akdeniz University Faculty of Medicine (1993–1999). He completed his Orthopedics and Traumatology residency at Akdeniz University (1999–2005).

Dr. Adil Turan is a specialist in Orthopedics and Traumatology. He completed medical school at Trakya University (1996–2003). He finished his residency at İzmir Bozyaka Training and Research Hospital (2004–2009). In 2020, he conducted trauma research at Denver Health Hospital in Denver, USA.

He worked at Kızıltepe State Hospital (2009–2010). He then served as an Orthopedic Specialist at Antalya Training and Research Hospital (2010–2013) and Ordu State Hospital (2013–2015). He was Chief Assistant at Antalya Training and Research Hospital (2016–2020). He was Associate Professor and Instructor at Antalya Training and Research Hospital (2020–2022) and at the Health Sciences University Antalya Health Application Center (2023).

His professional memberships include the Turkish Orthopedics and Traumatology Association, the Turkish Sports Injuries Arthroscopy and Knee Surgery Association, the Turkish Orthopedics and Traumatology Education Council (since 2016), and the Turkish Medical Association.

I was born in Adana in 1983. I graduated from Hacettepe University (ing) in 2007 and started to work as an orthopedic assistant at İzmir Atatürk Training and Research Hospital in 2008. I did my master's thesis on the rotator cuff healing of dicholefenac sodium. As a specialist in 2013, I started at Okmeydanı Training and Research Hospital and got my associate professorship there in 2018. In 2017, I worked as a Clinical fellow in the publication of Prof Dr Philip Lobenhoffer for Knee Circumferential Osteotomies, unicondylar and total knee arthroplasty in Germany (Go:h Sports Clinic/Hannover). I started working at Istinye University Hospital in 2019. I am married and have 2 children.

Research Areas: Knee surgery, Shoulder surgery, Ankle surgery, Artoplasty

Basic Areas: Orthopedics and Traumatology,

Awards

(2015), "Derviş Manizade Science Award", "Professional Associations", "Award received from domestic public institutions and organizations in the field", "Turkish Orthopedics and Traumatology Association", Science - Art Awards

(2017), "Tusyad Overseas Traveling Education Scholarship", "Professional Associations", "Award received from domestic public institutions and organizations in the field", "Turkish Sports Injuries Arthroscopy and Knee Surgery Association", Other

(2016), "Best Experimental Study Poster Award Winner", "Professional Associations", "Award from domestic public institutions and organizations", "Bone Joint Surgery Association", Other

(2015), "25th National Turkish Orthopedics and Traumatology Congress, first place in the poster category", "Professional Associations", "Award received from domestic public institutions and organizations in the field", "Turkish Association of Orthopedics and Traumatology Association", Work Award
 

Education and Expertise

Istanbul University Istanbul Faculty of Medicine - 2010

İstanbul Metin Sabancı Baltalimanı Bone Diseases Training and Research Hospital – Orthopedics and Traumatology – 2016

Work experiences

Private Family Hospital

Private Atakoy Hospital

Sancaktepe Health Center

Baltalimanı Bone Diseases Training and Research Hospital

Diyarbakir Selahaddin Eyyubi State Hospital

Subjects He Is Competent And Interested In:

Knee Calcification

Knee pain

Meniscus Tear

Knee Ligament Injuries

Carpal Tunnel Syndrome

Neck pain

Orthopedic Diseases

Shoulder Instability

Shoulder Dislocation

Shoulder pain

Meniscus

Recurrent Shoulder Dislocations

Hip and Knee Prosthesis

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Education:

• Degree: Faculty of Medicine, Trakya University, 2009
• Medical Specialty: Internal Medicine, Bakırköy Dr. Sadi Konuk Training and Research Hospital, 2010-2014
• Specialist Doctor: Internal Medicine, Kanuni Sultan Süleyman Training and Research Hospital, 2014-2019
• Specialist Doctor: Internal Medicine, Turkish Hospital Internal Medicine Clinic, Qatar, 2019-2020
• Specialist Doctor: Internal Medicine, Istanbul Medipol University Hospital Mega Hospital Internal Medicine Department, 2020-2024
• Associate Professor Doctor: Internal Medicine, Istanbul Medipol University Medipol Acıbadem Regional Hospital, 2024-Present.

Roles in Projects:

Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.

Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.

Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.

Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).

Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.

1997 - 2002 Universitas Istanbul Fakultas Kedokteran Cerrahpaşa, Departemen Ortopedi dan Traumatologi

1990 - 1996 Universitas Istanbul Fakultas Kedokteran Cerrahpasa

Artikel yang ditulis dan dikontribusikan oleh;

Efikasi klinis dari injeksi plasma kaya platelet peritendinous dalam pengobatan tendinopati: Studi retrospektif Aybars Kıvrak* (a), Mehmet Can Ünlü (a), Esref Terzi (a), Olgar Birsel (b), Doruk Akgun (c), Yusuf Pirincci (d), Gokhan Kaynak(a), Isik Akgun (e) Efek jangka menengah dan panjang dari cincin atap asetabular dan kerangka anti-protrusio Burch-Schneider dalam revisi asetabular pada pasien dengan defisiensi tulang asetabular Korespondensi: Yusuf Pirinççi, Muhammed Taha Demir, Mumammet Salih, Fahri Erdoğan, Nejat Güney

Variabel dimensional dari femur proksimal pada displasia pinggul dewasa perkembangan menunjukkan bahwa desain penyusutan berbentuk persegi panjang mungkin menjadi pilihan optimal untuk pasien dengan pinggul tipe IV Crowe

Spesialisasi

Pemanjangan Kaki 

Bedah Olahraga

Robekan Meniskus

Robekan Ligamen Krusiatum Anterior

Prostesis Lutut

Prostesis Pinggul

Prostesis Bahu

Perbaikan SLAP Bahu

Perpanjangan Tinggi Badan

Bedah Tumor

Bedah Kaki (Hallux Valgus)

Kaki Diabetik

Infeksi Tulang (Osteomielitis)

Education:

Bachelor's Degree

• Field: Faculty of Medicine
• University: Gazi University
• Years: 2009-2015

PhD/Medical Specialty

• Field: Department of Internal Medicine/Cardiology Department
• University: Mustafa Kemal University
• Years: 2016-2020

Experience:

General Practitioner

• Institution: Kırıkhan Community Health Center
• Years: 2015-2016

Research Assistant Doctor

• Institution: Hatay Mustafa Kemal University Faculty of Medicine Cardiology Department
• Years: 2016-2020

Specialist Doctor

• Institution: Hatay Training and Research Hospital
• Years: 2020-2022

Doctor Academic Staff

• Institution: Hatay Mustafa Kemal University Faculty of Medicine Cardiology Department
• Years: 2022-2024
•  

Experience

1989 - 1990

Diyarbakır Kulp Merkez Sağlık Ocağı

1990

Selçuk University Faculty of Medicine

1995

Konya State Hospital

1995

Selçuk University Faculty of Medicine

1997

600-Bed Golcuk Naval Hospital

1999

Selçuk University Meram Faculty of Medicine

2005

Selçuk University Meram Faculty of Medicine

2011

Selçuk University Selçuklu Faculty of Medicine

2020

Özel Bower Hospital

Education

1994 Selçuk University, Thoracic Surgery

1989 Gazi University, Faculty of Medicine

1989 Gazi University, Faculty of Medicine

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

• AREAS OF INTEREST
• Spine surgery
• Scoliosis
• Kyphosis
• Childhood spinal diseases
• Degenerative spine diseases
• Lumbar cervical disc herniation
• Knee hip joint disorders
• Orthopedic trauma surgery

• Education and Specialization
• 2010 - Cerrahpasa Faculty of Medicine - Medical Education
• 2016 - Medeniyet University Goztepe Training and Research Hospital - Specialization

• Experience
• 2016 - 2022 - Sisli Hamidiye Etfal Training and Research Hospital
• 2015 -2016 - Chicago Loyola University, Illinois, USA

• Courses and Certificates
• 13.12.2019-14.12.2019 Turkish Spine Society Eurospine Accredited Education Modules
• 08.11.2019-10.11.2019 Turkish Spine Society Eurospine Accredited Education Modules
• 31.08.2015-04.09.2015 Basic Microsurgery Course, MICROSURGERY EDUCATION-RESEARCH LABORATORY
• AO Trauma Course-Basic Principles of Fracture Management
• 07.06.2014-10.06.2014 Fracture Management, Kodi Kojima Chairperson AOTrauma Education Commission
• 01.03.2013-02.03.2013 Instrumentation in Arthroscopic Surgery

• Professional Memberships
• Turkish Orthopedics and Traumatology Association (TOTBİD)
• Turkish Medical Association - Istanbul Medical Chamber

Faculty of Medicine Hacettepe School of Medicine (1994-2001)

Specialty training: Istanbul Training and Research Hospital (2002-2008)

In 2015, he was awarded the title of Associate Professor.

On February 01, 2021, he was promoted to Professor.

Professional Positions:

• Consultant MD, Balıkesir Military Hospital (2008-2009)

• Consultant MD, Şanlıurfa Training and Research Hospital (2009-2011)

• Assistant Professor MD, Dicle University, Department of Orthopedics and Traumatology (2011-2017)

• Associate Professor MD, Istanbul Medipol University, Faculty of Medicine, Department of Orthopedics and Traumatology (2017-2020)

• Professor MD, Istanbul Medipol University, Faculty of Medicine, Department of Orthopedics and Traumatology (2021 – Ongoing)

Education

• 2002 - 2008, Ege University, Bachelor's Degree, Medical Doctor
• 2009 - 2013, Istanbul Bagcilar Training and Research Hospital, Specialization in Cardiology
• 2013 - 2018, Bezm-i Âlem Vakif University, Assistant Professor
• 2018 – 2021, Bezm-i Âlem Vakif University, Associate Professor

Experience

• 2009 - 2013, Istanbul Bagcilar Training and Research Hospital
• 2013, Istanbul Esenler Basaksehir State Hospital
• 2014, Bursa Mustafakemalpasa State Hospital
• 2013 – 2014, Ministry of Health Mehmet Akif Ersoy Hospital
• 2014 – 2016, Mustafakemalpasa State Hospital, Bursa
• 2016 – 2024, Bezm-i Âlem Vakif University
• 2024 – Present, Medipol Acibadem Hospital

Cardiology Department 

Education and Specialty: 

2003 - Medical Education, School of Medicine, Çukurova University 

2009 – Specialty, School of Medicine, Uludağ University 

2015- Associate Professor, Adana Training and Research Hospital 

Experience: 

2012 - 2015 – Head of Educational and Administrative Affairs, ENT Clinic, Haseki Training and Research Hospital (3 years) 

2009 – 2011, Conscription, Şevket Yılmaz Training and Research Hospital, Bursa 

2011-2013 Bursa State Hospital 

2013-2015 Seyhan Practice Hospital, Adana Training and Research Hospital 

2015-2016 Head of Department of Cardiology, Okmeydanı Training and Research Hospital 

February 2016 – July 2019, Head of Department of Cardiology, School of Medicine, Biruni University. 

Fields of Specialties: 

Complex Coronary Interventions 

Complex Peripheral Interventions 

Pacemaker Procedures 

Electrophysiological Study and Ablation 

Heart Valve Interventions (TAVI, Mitraclip, Mitral Balloon) 

Certificates: 

Board Certificate, European Society of Cardiology 

Board Certificate, Turkish Society of Cardiology 

Professional Memberships- Number Insignificant: 

1. European Society of Cardiology 

2. Turkish Society of Cardiology 

3. Member of Istanbul Medical Chamber 

Personal motto: Your heart is entrusted to us 

Researches and Articles: 

Articles published in international peer-review journals: 

1. *Uçar H*, Gür M, Koyunsever NY, Seker T, Türkoglu C, Kaypakli O, Sahin DY, Elbasan Z, Cayli M. Mean platelet volume is independently associated with renal dysfunction in stable coronary artery disease. Platelets (ISI). 2013 Jun; 25(4):274-278. doi: 10.3109/09537104.2013.805406. Epub 2013 Jun 17 

A2. *Uçar H*, Gür M, Yildirim A, Börekçi A, Gözükara MY, Seker T, Kaypakli O, Türkoglu C, Ozaltun B, Akyol S, Harbalioglu H, Sahin DY, Elbasan Z, Cayli M. Increased Aortic Stiffness Predicts Contrast-Induced Nephropathy in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Angiology (ISI). 2014 Oct;65(9):806-11. doi: 10.1177/0003319713504126. Epub 2013 Sep 26. 

A3. *Uçar H*, Gür M, Kivrak A, Koyunsever NY, Seker T, Akilli RE, Türkoglu C, Kaypakli O, Sahin DY, Elbasan Z, Tanboga HI, Cayli M. High-sensitivity cardiac troponin T levels in newly diagnosed hypertensive patients with different left ventricle geometry. Blood Pressure (ISI). 2014 Aug;23(4):240-7. doi: 10.3109/08037051.2013.840429. Epub 2013 Sep 23. 

A4. *Uçar H*, Mustafa Gür M, Gözükara MY, Kıvrak A, Kolcu Z, Akyol S, Kaypaklı O, Elbasan Z, Sahin DY, Türkoglu C, Seker T, Çaylı M. Relationship between mean platelet volume and morning blood pressure surge in newly diagnosed hypertensive patients. The Anatolian Journal of Cardiology (ISI). 2014 Apr 8. doi: 10.5152/akd.2014.5196. [Epub ahead of print]. 

A5. *Uçar H*, Gür M, Seker T, Kaypaklı O, Elbasan Z, Koyunsever NY, Türkoglu C, Özaltun B, Kuloglu O, Kalkan GY, Sahin DY, Çaylı M. High-Sensitivity Cardiac Troponin T is Associated with SYNTAX Score and Diabetes Mellitus in Patients with Stable Coronary Artery Disease. Journal of Clinical & Experimental Cardiology , 2013 Jun; 4(9):1-5. doi: 10.4172/2155-9880.1000263 

A6. *Uçar H*, Gür M, Gözükara MY, Kalkan GY, Baykan AO, Türkoğlu C, Kaypakl O, Seker T, Sen O, Selek S, Cayl M. Gamma glutamyl transferase activity is Independently associated with oxidative stress rather than SYNTAX score. Scand J Clin Lab Invest (ISI). 2014 Sep 2:1-6. [Epub ahead of print] 

A7. *Uçar H*, Gür M, Börrekçi A, Yıldırım A, Baykan AO, Kalkan GY,Koç M, Şeker T, Coşkun M, Şen Ö, Çaylı M. Relationship between extent and complexity of coronary artery disease and different left ventricular geometric patterns in patients with coronary artery disease and hypertension. The Anatolian Journal of Cardiology (ISI). DOI:10.5152/akd.2014.5747 

A8. Çaylı M, Elbasan Z, Gür M, Şeker T, *Uçar H*, Kuloğlu O, Şen O, Şahin DY, Yüksel Kalkan G. Modified flower petal technique in the treatment of isolated ostial left main and non-left main bifurcation lesions. Eurointervention. Accepted 2014 Oct. 20140324-02-R2 

A9. Baykan AO, Yüksel Kalkan G, Gür M, *Uçar H*, Acele A, Seker T, Sen O, Kaypakli O, Harbalioğlu H, Cayli M. Coronary Flow Velocity Reserve in Patients with Ascending Aorta Aneurysm. Echocardiography (ISI). 2014 Oct 7. doi: 10.1111/echo.12782. [Epub ahead of print] 

A10. Şeker T, Gür M, *Uçar H*, Türkoğlu C, Baykan AO, Özaltun B, Harbalıoğlu H, Kalkan GY, Kaypaklı O, Kuloğlu O, Şen Ö, Koç M, Çaylı M. Lower serum 25-hydroxyvitamin D level is associated with impaired myocardial performance and left ventricle hypertrophy in newly diagnosed hypertensive patients. The Anatolian Journal of Cardiology (ISI). DOI:10.5152/akd.2014.5637 

A11. Gözükara MY, Börekçi A, Gür M, Aksoy N, Seker T, Kaypaklı O, *Uçar H*, Türkoğlu C, Koç M, Makca I, Akyol S, Selek S, Caylı M. Gamma Glutamyl Transferase Activity is Associated With Both Paraoxonase Activity and Aortic Stiffness in Hypertensive Patients. J Clin Lab Anal (ISI). 2014 Aug 17. doi: 10.1002/jcla.21785. [Epub ahead of print] 

A12. Kalkan GY, Gür M, Baykan AO, *Uçar H*, Elbasan Z, Şahin DY, Koç M, Börekçi A, Çaylı M. Mean platelet volume is associated with aortic intima-media thickness in patients without clinical manifestation of atherosclerotic cardiovascular disease. The Anatolian Journal of Cardiology (ISI). DOI:10.5152/akd.2014.5576 

A13. Gür M, Türkoglu C, Taskın A, *Uçar H*, Börekçi A, Seker T, Gözükara MY, Kaypaklı O, Akyol S, Selek S, Sahin DY, Elbasan Z, Çayli M. Paraoxonase 1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow. Atherosclerosis (ISI). 2014 Jun;234(2):415-20. doi: 10.1016/j.atherosclerosis.2014.03.005. Epub 2014 Apr 3. 

A14. Sahin DY, Gür M, Elbasan Z, Kırım S, *Uçar H*, Seker T, Kaypaklı O, Uysal OK, Kıvrak A, Koyunsever NY, Akıllı RE, Caylı M. NT-proBNP predicts impaired myocardial function in newly diagnosed hypertensive patients with preserved ejection fraction. Clinical and Experimental Hypertension (ISI). 2014;36(5):289-94. doi: 10.3109/10641963.2013.810234. Epub 2013 Jul 18. 

A15. Caylı M, Gür M, Kalkan GY, Elbasan Z, Sahin DY, Koyunsever NY, Türkoglu C, Seker T, Kaypaklı O, Harbalıoglu H, Uçar. Gamma glutamyl transferase activity: Relationship with thoracic aortic intima media thickness and inflammation. Herz (ISI). 2014 Sep;39(6):761-766. Epub 2013 Aug 11. 

A16. Çaylı M, Gür M, Elbasan Z, Seker T, Türkoglu C, Kaypaklı O, Sahin DY, *Uçar H*, Kıvrak A, Koyunsever NY, Sen Ö. High-sensitivity cardiac troponin T predicts nondipper hypertension in newly diagnosed hypertensive patients. J Clin Hypertens (Greenwich) (ISI). 2013 Oct;15(10):731- 6. doi: 10.1111/jch.12176. Epub 2013 Aug 7. 

A17. Kalkan GY, Gür M, Baykan AO, Koyunsever NY, Kaypakli O, Sen O, Kuloglu O, Seker T, *Uçar H*, Akyol S, Elbasan Z, Sahin DY, Çayli M. Serum bilirubin level and aortic intima-media thickness in patients without clinical manifestation of atherosclerotic cardiovascular disease. Angiology (ISI). 2014 Apr;65(4):308-12. doi: 10.1177/0003319713507627. Epub 2013 Oct 24. 

A18. Gür M, *Uçar H*, Kuloglu O, Kıvrak A, Seker T, Türkoglu C, Ozaltun B, Kaypaklı O, Sahin DY, Elbasan Z, Tanboga HI, Caylı M. Estimated glomerular filtration rate is associated with both arterial stiffness and N-terminal pro-brain natriuretic peptide in newly diagnosed hypertensive patients. Clinical and Experimental Hypertension (ISI). 2014;36(6):374-9. doi: 10.3109/10641963.2013.827703. Epub 2014 Jan 16. 

A19. Gür M, Caylı M, *Uçar H*, Elbasan Z, Sahin DY, Gözükara MY, Selek S, Koyunsever NY, Seker T, Türkoglu C, Kaypaklı O, Aksoy N. Paraoxonase (PON1) activity in patients with subclinical thoracic aortic atherosclerosis. Int J Cardiovasc Imaging (ISI). 2014 Jun;30(5):889-95. doi: 10.1007/s10554-014-0407-y. Epub 2014 Apr 4. 

A20. Budak YU, Huysal K, Polat M, Tarakçi G, *Uçar H*. Evaluation of the Steelex M600H coagulometer prothrombin time-international normalized ratio assay with Steelex test reagents. Biochem Med (Zagreb) (ISI). 2012 Jan; 22: 121-126 pp. 

A21. Seker T, Türkoglu C, *Uçar H*, Gür M, Sahin DY, Caylı M. Treatment of totally occluded aortic coarctation using a covered stent. Herz (ISI). 2014 Mar; DOI: 10.1007/s00059-013-3984-y [Epub ahead of print] 

A22. Börekçi A, Gür M, Türkoğlu C, Çaylı M, Selek S, Kaypaklı O, *Uçar H*, Coskun M, Seker T, Koç M, Gökdeniz T, Gözükara MY. Oxidative Stress and Paraoxonase 1 Activity Predict ContrastInduced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology (ISI). 2014 May; DOI: 10.1177/0003319714533588 [Epub ahead of print] 

A23. Kalkan GY, Gür M, Haydardedeoglu FE , Sinan Kırım S, Baykan AO, Kuloglu O, *Uçar H*, Sahin DY, Elbasan Z, Seker T, Turkoglu C, Yildirim A, Cayli M. The Association between Aortic Distensibility and Coronary Flow Reserve in Newly Diagnosed Diabetic Patients. Echocardiography (ISI). 2014 May; DOI: 10.1111/echo.12631 [Epub ahead of print] 

A24. Kalkan GY, Gür M, Koyunsever NY, Seker T, Gözükara MY, *Uçar H*, Kaypaklı O, Baykan AO, Akyol S, Türkoglu C, Elbasan Z, Sahin DY, Çaylı M. Serum 25-hydroxyvitamin D level and aortic intima-media thickness in patients without clinical manifestation of atherosclerotic cardiovascular disease. Journal of Clinical Laboratory Analysis (ISI). 2014 Aug 17. doi: 10.1002/jcla.21770. [Epub ahead of print]. 

A25. *Uçar H*, Karaagaç K, Serdar OA, Yetkin ZA, Aktürk Y, Karaagaç EU, Sarıcaoglu H, Arterial Elasticity Measurement in Patients with Behçet Disease. HealthMED (2012’ de ISI) 2012 May; 6: 3255-3261 pp. 

A26. Karaagaç K, *Uçar H*, Karaagaç E, Yetkin ZA, Aktürk Y. The Relation Betwen Aspirin Resistance and Mean Platelet Volume in Patients with Significant Coronary Artery Stenosis. HealthMED (2012’ de ISI) 2012 May ;6: 3701-3705 pp. 

A27. Cander S, Coban S Altuner S, Gül ÖÖ, Yetgin ZA, Akkurt A, *Uçar H*, Tuncel E. Prevalence and Correlates of Erectile Dysfunction in Type 2 Diabetes Mellitus: A Cross-Sectional SingleCenter Study Among Turkish Patients. Metabolic Syndrome and Related Disorders (ISI). 2014 Aug;12(6):324-9. doi: 10.1089/met.2013.0150. Epub 2014 Mar 25. 

A28. Abalı G, *Uçar H*, Elbasan Z , Gür M ,Seker T, Koyunsever NY, Çaylı M, Akpınar O. Effect of Statin on Neutrophil to Lymphocyte Ratio in Patients with Coronary Artery Disease. Experimental & Clinical Cardiology (ISI). 2014 May 

A29. Effect of fasting on 24-h blood pressure values of individuals with no previous history of hypertension. Seker A, Demirci H, Ocakoglu G, Aydin U, Ucar H, Yildiz G, Yaman O. Blood Press Monit. 2017 Oct;22(5):247-252. doi: 10.1097/MBP.0000000000000244 

A30. The importance of the neutrophil-to-lymphocyte ratio in patients with hypertrophic cardiomyopathy. Ozyilmaz S, Akgul O, Uyarel H, Pusuroglu H, Gul M, Satilmisoglu MH, Bolat I, Ozyilmaz I, *Uçar H*, Yildirim A, Bakir I. Rev Port Cardiol. 2017 Apr;36(4):239-246. doi: 10.1016/j.repc.2016.09.014. Epub 2017 Mar 18. English, Portuguese 

A31. A case of stent thrombosis presenting as acute myocardial infarction related to right coronary artery originating from the left coronary system. Ermis E, Kahraman S, Ucar H, Allahverdiyev S. Intractable Rare Dis Res. 2018 Feb;7(1):58-60. doi: 10.5582/irdr.2018.01001. 

A32. Triple Coronary Artery Thrombosis Presenting as Acute Anterior ST-Segment Elevation Myocardial Infarction. Ermis E, Kahraman S, Ucar H, Ozyılmaz SO, Allahverdiyev S. Int J Angiol. 2018 Dec;27(4):223-226. doi: 10.1055/s-0037-1608959. Epub 2017 Dec 12 

A33. Relationship between blood pressure variability and cognitive function in geriatric hypertensive patients with well-controlled blood pressure. Yıldırım E, Ermis E, Allahverdiyev S, Ucar H, Yavuzer S, Yavuzer H, Cengiz M. Aging Clin Exp Res. 2019 Feb 1. doi: 10.1007/s40520- 019-01141-6. 

C2. Book chapters written in other languages: 

C2.1. Hung JS, Lau KW, *Uçar H*, Çaylı M, Çaylı M, Practical Handbook: Practical Handbook of Advanced Interventional Cardiology (Inoue balloon mitral valvuloplasty),437-473 pp, Adana / Turkey, Çukurova Nobel Medical Bookstore, 2014 

C2.2. Feldman T, Nguyen TN, *Uçar H*, Çaylı M, Çaylı M, Practical Handbook: Practical Handbook of Advanced Interventional Cardiology (retrograde percutaneous aortic valvuloplasty), 475-486 pp, Çukurova, Adana / Turkey, Çukurova Nobel Medical Bookstore, 2014 

D. Articles published in local peer-review journals: 

D1. *Uçar H*, Gür M, Seker T, Sahin DY, Kalkan GY, Türkoglu C, Yıldırım A, Kaypaklı O, Elbasan Z, Çaylı M. Impaired kidney function is associated with syntax scorein patients with stable coronary artery disease. Archive of Turkish Society of Cardiology, 2014; DOI: 10.5543/tkda.2014.67790 

D2. Kalkan GY, Gür M, Elbasan Z, Baykan AO, Kuloğlu O, Sahin DY, Seker T, Haydardedeoglu FE, Şen Ö, *Uçar H*, Kırım S, Çayli M. Left Ventricle Geometry Affects Coronary Flow Reserve in Diabetic Patients. Archive of Turkish Society of Cardiology, Doi: 10.5543/tkda.2015.59432 

D3. *Uçar H*, Karaagaç K, Tiryakioglu S. Woven Left Coronary Artery: A Case Report. Turkish Clinics Journal of Medical Research-Case Reports 2014 (22), 5-6 pp. 

D4. Albayrak S, Kemal Karaagaç K, Baran I, Yetgin ZA, *Uçar H*, Aydınlar A, "Carvedilol and Metoprolol in Acute Myocardial Infarction Early Effect of Oxidized LDL and Paraoxonase-1 Activity Abant Medical Journal 2013; DOI: 10.5505/abantmedj.2013.30592 

D5. Gür AK, Eker E, Akyol A, Akdag S, Kolcu Z, Odabası D, *Uçar H*. Useage of Intra-aortic Baloon Pump in the Open Heart Surgeries. Medical Journal of School of Medicine, Harran University 2014 (11), 10-14 pp. 

D6. Aktürk Y, Dilek Yesilbursa D, *Uçar H*, Yücel E, Özdabakoglu O, Eryılmaz S, Sensoy B, Serdar OA, Aydınlar A. The Effect of Diurnal Blood Pressure Change on Heart Rate Recovery After Cardiac Stress Testing in Hypertensive Patients Receiving Treatment. Uludağ University, School of Medicine Journal 2008 (34), 9-13 pp. 

D7. Yesilbursa D, Aydinlar A, Karaagaç K, *Uçar H*, Aktürk Y, Yetgin ZA. Comparison of Depression and Anxiety Levels in Patients With Acute Coronary Syndrome. Journal of Clinical and Analytical Medicine 2014; DOI: 10.4328/JCAM.1443 

D8. Emül A, Karaagaç K, Yetgin ZA, *Uçar H*, Baran I, Aydınlar A. The Effects of Metabolic Syndrome on Aortic Distensibility in Patients with Angiographically Normal Coronary Arteries. Sakarya Medical Journal 2013; DOI: 10.5505/sakaryamj.2013.69672 

D9. Assessment of side branch patency using a jailed semi-inflated balloon technique with coronary bifurcation lesions. Ermiş E, *Uçar H*, Demirelli S, İpek E, Gür M, Çaylı M. Archive of Turkish Society of Cardiology 2018 Jul;46(5):340-348. doi: 10.5543/tkda.2018.47347.

Personal Information

Name Surname: İbrahim COŞKUNER

Birthplace - Year: 1964

Academic Title: Op. Dr.

Foreign Language: English

Education

Karadeniz University Faculty of Medicine

SB Ankara Hospital

Work Experience

Bursa City Hospital 2020

Artvin State Hospital 2005

Osteoarthritis Treatment; Intra-articular Botox Application

Treatment of Nonunion Fractures with new generation Composite Implants

Use of Composite Implants in early Fracture Healing

Joint Replacement in Hip and Knee Arthritis; Replacement of Joint with Prosthesis - Quality Metal Implants

Stem Cell Applications in Developmental Disorders

Knee Ligament Injury Repair Reconstructive Interventions

Spine Curvature Treatment Surgical Intervention

Ilizarov System Applications Surgical Treatment of Open Fractures, Correction of Deformities

Trauma to the bone structures

Knee Surgery

Structural Bone Disorders

Hand Surgery Athlete Traumatology

Pediatric Surgery

Intra-Articular Injections

PRP Injection

Anterior Cruciate Ligament Surgery

Professional Experience

• 1999-2000: Şırnak Military Hospital, Military Service
• 2001-2007: Süreyyapaşa Chest, Heart, and Vascular Diseases Hospital, Cardiovascular Surgery Clinic
  • Contributed to the establishment of the Cardiovascular Surgery Clinic
  • 2005: Awarded the title of Associate Professor in Cardiovascular Surgery
• 2007-2009: Kartal Koşuyolu High Specialization Training and Research Hospital
• 2009-2011: Kartal Koşuyolu High Specialization Training and Research Hospital, Cardiovascular Surgery Clinic, Assistant Chief
• 2011-2017: Kartal Koşuyolu High Specialization Training and Research Hospital, Cardiovascular Surgery Clinic, Instructor
• 2016-2017: Kartal Koşuyolu High Specialization Training and Research Hospital, Cardiovascular Surgery Clinic, Education Officer
• 2017-2024: Bezmialem Vakıf University, Faculty of Medicine, Professor
  • Head of Cardiovascular Surgery Department, Bezmialem Vakıf University, Faculty of Medicine
• Since July 2024: Medipol Acıbadem District l Hospital, Cardiovascular Surgeon

Dr. Humayun Kakar is a cardiologist. He earned his medical degree from Eskişehir Osmangazi University between 2007 and 2014. He completed his cardiology residency at İzmir Dokuz Eylül University from 2015 to 2020. In 2024, he received advanced training in heart failure at the University of Zurich in Switzerland.

He has worked at İzmir Ekonomi Üniversitesi Medical Point Hospital and Konya Cihanbeyli State Hospital. He also took part in advanced heart failure education at the University of Zurich.

Dr. Kakar is a member of several professional organizations. These include the European Society of Cardiology, Turkish Society of Cardiology, Heart Failure Association, American College of Cardiology, Cardiovascular Academy Association, and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).